Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 968,000 | 5,275,000 | 3,735,000 | 2,150,000 | 883,000 |
| Depreciation Amortization | 227,000 | 1,150,000 | 841,000 | 614,000 | 319,000 |
| Accounts receivable | 57,000 | 223,000 | 713,000 | 752,000 | 221,000 |
| Accounts payable and accrued liabilities | -206,000 | -731,000 | -234,000 | -674,000 | -12,000 |
| Other Working Capital | -95,000 | -555,000 | 412,000 | 5,000 | 151,000 |
| Other Operating Activity | 236,000 | 983,000 | -63,000 | 308,000 | 32,000 |
| Operating Cash Flow | $1,187,000 | $6,345,000 | $5,404,000 | $3,155,000 | $1,594,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -88,000 | -333,000 | -238,000 | -256,000 | -162,000 |
| Net Acquisitions | N/A | -688,000 | -780,000 | -780,000 | -671,000 |
| Purchase Of Investment | N/A | -2,550,000 | -1,825,000 | N/A | N/A |
| Sale Of Investment | 1,575,000 | 1,153,000 | 630,000 | 630,000 | 629,000 |
| Other Investing Activity | 0 | 0 | 1,000 | 0 | 0 |
| Investing Cash Flow | $1,487,000 | $-2,418,000 | $-2,212,000 | $-406,000 | $-204,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -601,000 | 1,000,000 | N/A | N/A | N/A |
| Debt Issued | N/A | 14,586,000 | N/A | N/A | N/A |
| Common Stock Issued | 91,000 | N/A | 0 | N/A | N/A |
| Common Stock Repurchased | -97,000 | N/A | 0 | N/A | N/A |
| Dividend Paid | -636,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -339,000 | -13,655,000 | -458,000 | -2,702,000 | -1,376,000 |
| Financing Cash Flow | $-1,582,000 | $1,931,000 | $-458,000 | $-2,702,000 | $-1,376,000 |
| Exchange Rate Effect | -14,000 | 16,000 | N/A | N/A | N/A |
| Beginning Cash Position | 5,901,000 | 27,000 | 27,000 | 27,000 | 27,000 |
| End Cash Position | 6,979,000 | 5,901,000 | 2,761,000 | 74,000 | 41,000 |
| Net Cash Flow | $1,078,000 | $5,874,000 | $2,734,000 | $47,000 | $14,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,187,000 | 6,345,000 | 5,404,000 | 3,155,000 | 1,594,000 |
| Capital Expenditure | -88,000 | -333,000 | -238,000 | -256,000 | -162,000 |
| Free Cash Flow | 1,099,000 | 6,012,000 | 5,166,000 | 2,899,000 | 1,432,000 |